Avid Bioservices (Avid Bioservices) EV-to-EBIT : -38.30 (As of May. 05, 2024)

Avid Bioservices EV-to-EBIT Chart

Avid Bioservices Annual Data
	Trend	Apr14	Apr15	Apr16	Apr17	Apr18	Apr19	Apr20	Apr21	Apr22	Apr23
EV-to-EBIT		Get a 7-Day Free Trial					-44.39	-32.05	101.44	57.90	278.57

Avid Bioservices Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
EV-to-EBIT	Get a 7-Day Free Trial															244.73	278.57	-11,069.32	-64.05	-33.06

Competitive Comparison of Avid Bioservices's EV-to-EBIT

For the Biotechnology subindustry, Avid Bioservices's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avid Bioservices's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avid Bioservices's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Avid Bioservices's EV-to-EBIT falls into.

Avid Bioservices EV-to-EBIT Calculation

Avid Bioservices's EV-to-EBIT for today is calculated as:

Avid Bioservices's current Enterprise Value is $687.9 Mil.
Avid Bioservices's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-18.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avid Bioservices  (NAS:CDMO) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Avid Bioservices's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2024 is calculated as:

Avid Bioservices's Enterprise Value for the quarter that ended in Jan. 2024 was $593.8 Mil.
Avid Bioservices's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-18.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avid Bioservices EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Avid Bioservices's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Avid Bioservices (Avid Bioservices) Business Description